drugset / Trial / NCT01462786
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
RandomizedCrossoverOpen-labelTreatment
Summary
The objectives of this trial are to evaluate the safety and tolerability of ATX-101 injections and to compare the pharmacokinetic profile of ATX-101 administered into subcutaneous fat in the submental area and abdomen.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-11
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATX-101 | Peptide | 2 unknown | Subcutaneous |
Indications
No indication recorded.